Delivery Order SPE2DB22D3016-SPE2DB25FASV0
Award Date
4/1/25
Potential Completion Date
4/22/25
Potential Value
$7.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,056.20 firm fixed-price delivery order is for the supply of 4566166957 ONIVYDE 43 MG/10 ML VIAL 10ML, with a completion date of November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a $5,056.20 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product. This contract has a completion date of June 20, 2024 and a firm fixed price pricing type. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,563.78 firm fixed-price delivery order is for the supply of the specialty drug ONIVYDE 43 MG/10 ML VIAL 10ML. The contract has an ultimate completion date of March 31, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
This federal contract award, valued at $6,741.60, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of ONIVYDE 43 MG/10 ML VIAL 10ML, a pharmaceutical product, to support military treatment programs and facilities. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded multiple Indefinite Delivery Contracts...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,046.06 firm fixed-price delivery order is for the supply of POLIVY 140 MG VIALS and has an ultimate completion date of April 23, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $20,908.66, is for the delivery of POLIVY 140 MG VIALS, a specialty medication, to support various government healthcare programs and facilities. The contract has an ultimate completion date of October 9, 2024, and is a firm fixed-price delivery order. This award is likely part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $11,023.03, is for the supply of 4567037176 - POLIVY 140 MG VIALS. The contract has an ultimate completion date of February 14, 2025 and is a firm fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $11,037.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of POLIVY 30 MG VIALS, a medical product. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $44,092.12, is for the delivery of POLIVY 140 MG VIALS. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 21, 2025. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a delivery order valued at $13,514.50 for the supply of OGIVRI 420 MG VIALS. The contract has an ultimate completion date of June 14, 2024 and was awarded on June 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen, a large pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical as the primary vehicle...